1 Min Read
Sept 30 (Reuters) - Midatech Pharma Plc
* Says commencement of first in human immunotherapy study using gold nanoparticle technology
* Results from study are expected in 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.